Inventor · disambiguated record
Henri Doods
Also filed as: DOODS HENRI · DOODS HENRI N
78 granted patents·35 pending applications·924 citations·filing 1988–2023
99Inventor score
Files withBOEHRINGER INGELHEIM INT38BOEHRINGER INGELHEIM PHARMA13THOMAE GMBH DR K13CENTREXION THERAPEUTICS CORP8GOTTSCHLING DIRK8
Top patents by PatentIndex Score
113 records- 0198US7279471B2Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Oct 9, 2007·48 cites·7 claims
- 0298US6521609B1Use of CGRP antagonists and CGRP release inhibitors for combating menopausal hot flushesBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Feb 18, 2003·122 cites·13 claims
- 0396US7479488B2Selected CGRP—antagonists, process for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jan 20, 2009·63 cites·28 claims
- 0496US7291642B2Bradykinin-B1 antagonists, process for their preparation and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Nov 6, 2007·64 cites·8 claims
- 0596US6344449B1Modified aminoacids, pharmaceuticals containing these compounds and method for their productionTHOMAE GMBH DR K·Filed 1997·Granted Feb 5, 2002·158 cites·3 claims
- 0696US6313097B1Antagonists of calcitonin gene-related peptideBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Nov 6, 2001·93 cites·13 claims
- 0794US7696209B2CGRP-antagonists, process for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2009·Granted Apr 13, 2010·24 cites·10 claims
- 0892US8110575B2CompoundsGOTTSCHLING DIRK·Filed 2008·Granted Feb 7, 2012·30 cites·20 claims
- 0991US11725004B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Aug 15, 2023·1 cites·16 claims
- 1091US11084810B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2020·Granted Aug 10, 2021·2 cites·18 claims
- 1190US7439237B2Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2007·Granted Oct 21, 2008·8 cites·5 claims
- 1289US10570125B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Feb 25, 2020·4 cites·20 claims
- 1389US7205294B2Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Apr 17, 2007·14 cites·5 claims
- 1488US10112934B2(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Oct 30, 2018·4 cites·25 claims
- 1586US12344601B2(cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesCENTREXION THERAPEUTICS CORP·Filed 2023·Granted Jul 1, 2025·0 cites·20 claims
- 1686US9789082B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2016·Granted Oct 17, 2017·5 cites·38 claims
- 1786US8865744B1(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazolesRIETHER DORIS·Filed 2014·Granted Oct 21, 2014·8 cites·5 claims
- 1886US7807666B2CGRP antagonistsBOEHRINGER INGELHEIM INT·Filed 2007·Granted Oct 5, 2010·9 cites·1 claims
- 1985US10675268B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Jun 9, 2020·2 cites·15 claims
- 2085US10166214B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Jan 1, 2019·4 cites·25 claims
- 2185US8372838B2Compounds as bradykinin B1 antagonistsBOEHRINGER INGELHEIM INT·Filed 2011·Granted Feb 12, 2013·6 cites·15 claims
- 2284US7498325B2Modified amino acids, pharmaceuticals containing these compounds and method for their productionKARL THOMAS GMBH·Filed 2004·Granted Mar 3, 2009·23 cites·5 claims
- 2384US7491717B2Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2006·Granted Feb 17, 2009·6 cites·6 claims
- 2484US6114390AAmino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing themTHOMAE GMBH DR K·Filed 1997·Granted Sep 5, 2000·35 cites·10 claims
- 2583US9371282B2Somatostatin receptor subtype 4 (SSTR4) agonistsCT XION THERAPEUTICS CORP·Filed 2014·Granted Jun 21, 2016·8 cites·48 claims
- 2682US7230001B1Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereofBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Jun 12, 2007·16 cites·9 claims
- 2782US5106851ABenzofused-n-containing heterocycle derivativesANGELI INST SPA·Filed 1990·Granted Apr 21, 1992·31 cites·6 claims
- 2880US8450306B2Bradykinin B1-receptor antagonistsHAUEL NORBERT·Filed 2008·Granted May 28, 2013·5 cites·4 claims
- 2980US7579341B2Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2006·Granted Aug 25, 2009·3 cites·23 claims
- 3080US7528129B2CGRP-antagonists, process for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2006·Granted May 5, 2009·3 cites·20 claims
- 3179US8486968B2CompoundsPRIEPKE HENNING·Filed 2011·Granted Jul 16, 2013·6 cites·14 claims
- 3279US7582625B2Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2006·Granted Sep 1, 2009·3 cites·10 claims
- 3379US5962530AAmino acid derivatives, medicaments containing said compounds and methods of producing themTHOMAE GMBH DR K·Filed 1996·Granted Oct 5, 1999·23 cites·8 claims
- 3478US7625886B2Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2006·Granted Dec 1, 2009·3 cites·3 claims
- 3577US8952014B2Pyrimidine derivatives which are CGRP—antagonistsGOTTSCHLING DIRK·Filed 2009·Granted Feb 10, 2015·3 cites·8 claims
- 3677US8450327B2CGRP antagonistsGOTTSCHLING DIRK·Filed 2008·Granted May 28, 2013·3 cites·23 claims
- 3776US5011836AAgents for the treatment of acute and chronic obstructive respiratory passage diseasesTHOMAE GMBH DR K·Filed 1989·Granted Apr 30, 1991·20 cites·4 claims
- 3873US5616620AAmino acid derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of obesityTHOMAE GMBH DR K·Filed 1995·Granted Apr 1, 1997·13 cites·8 claims
- 3972US7858618B2CompoundsBOEHRINGER INGELHEIM INT·Filed 2007·Granted Dec 28, 2010·1 cites·2 claims
- 4070US8951999B2CompoundsPRIEPKE HENNING·Filed 2010·Granted Feb 10, 2015·2 cites·2 claims
- 4170US5807875AAmino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing themTHOMAE GMBH DR K·Filed 1996·Granted Sep 15, 1998·13 cites·8 claims
- 4268US8921405B2CompoundsPFAU ROLAND·Filed 2013·Granted Dec 30, 2014·1 cites·18 claims
- 4368US7595312B2Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Sep 29, 2009·3 cites·66 claims
- 4467US8916599B21H-benz imidazole-5-carboxamides as anti-inflammatory agentsPFAU ROLAND·Filed 2009·Granted Dec 23, 2014·0 cites·4 claims
- 4567US8674113B2CompoundsPRIEPKE HENNING·Filed 2011·Granted Mar 18, 2014·1 cites·13 claims
- 4666US9040565B21H-benzimidazole-5-carboxamides as anti-inflammatory agentsPFAU ROLAND·Filed 2009·Granted May 26, 2015·0 cites·7 claims
- 4766US8759537B23H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agentsPRIEPKE HENNING·Filed 2011·Granted Jun 24, 2014·1 cites·27 claims
- 4866US8703796B23H-imidazo [4, 5-B] pyridine-6-carboxamides as anti-inflammatory agentsPFAU ROLAND·Filed 2009·Granted Apr 22, 2014·0 cites·4 claims
- 4966US8598190B23H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agentsPFAU ROLAND·Filed 2009·Granted Dec 3, 2013·0 cites·18 claims
- 5066US8586604B2Inhibitors of the microsomal prostaglandin E2 synthase-1PRIEPKE HENNING·Filed 2011·Granted Nov 19, 2013·1 cites·15 claims
Showing the top 50 of 113 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Henri Doods files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →